A Phase II Trial of Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Neuroendocrine Carcinoma Article

Full Text via DOI: 10.1016/j.jtho.2019.08.1750 Web of Science: 000492162204235

Cited authors

  • Ramirez, R.; Matrana, M.; Satti, S.; Voros, B.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 1556-0864

Start page

  • S813

End page

  • S814


  • 14


  • 10